Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
MONET1-MOtesanib NSCLC Efficacy and Tolerability Study
- Status
- TERMINATED
- Phase
- PHASE3
Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR
- Status
- COMPLETED
- Phase
- PHASE3
A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)
- Status
- TERMINATED
- Phase
- PHASE2
Alimta and Gemcitabine in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
- Status
- COMPLETED
- Phase
- NA
Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058)
- Status
- COMPLETED
- Phase
- PHASE1
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery
- Status
- UNKNOWN
- Phase
- PHASE3